Women's Health Habits Study

Brigham and Women's Hospital611 enrolled

Overview

The purpose of this randomized trial is to test the effectiveness of screening and brief intervention for risk drinking by nonpregnant women with specific medical problems exacerbated by excessive alcohol consumption. The medical problems are female factor infertility, hypertension, diabetes, and osteoporosis, conditions that are costly to treat and difficult to manage. Just as pregnant women are thought to be highly motivated to modify their alcohol consumption, so women with specific medical problems worsened by alcohol intake are an appropriate group to receive a brief intervention.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Enrollment

611

Conditions

Risk Drinking,Diabetes, Hypertension, Osteoporosis, Infertility

Interventions

Brief InterventionBEHAVIORAL

Diagnostic assessment followed by a single session Brief Intervention with 3, 6, and 12 month follow-up

Diagnostic assessmentBEHAVIORAL

Single session diagnostic assessment with 12 month followup

Eligibility

Sex: FEMALEMin age: 21 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: \- 1. has diabetes, hypertension, osteoporosis, or infertility 2. Not currently receiving treatment for alcohol or drug problems or substance related medical illness 3. Not currently experiencing physical dependence on alcohol, requiring medically supervised detoxification 4. Not currently abusing or physically dependent on opiates, cocaine, or other illicit drugs 5. Not currently pregnant. Subjects with infertility may become pregnant during the course of the study. 6\. Not currently nursing. 7. Able to complete study measures. Exclusion Criteria: 1. Alcohol screen negative or drinks within NIAAA sensible drinking limits for women 2. Does not agree to randomization and study terms

Locations (1)

Brigham and Women's Hospital

Boston, Massachusetts, United States

Outcomes

Primary Outcomes

Drinking outcome

Time frame: 12 months post enrollment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.